Veraxa Biotech Holding AG (VRXA) Goodwill (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted quarterly Goodwill of $28.6 million for Q4 2025, up 9.61% year-over-year from $26.1 million in Q4 2024, and up 9.61% quarter-over-quarter from $26.1 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Goodwill (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Goodwill for 2 consecutive years, with $28.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Goodwill rose 9.61% year-over-year to $28.6 million; the TTM figure through Dec 2025 stood at $28.6 million (up 9.61% YoY), while the FY2025 annual figure was $28.6 million, up 9.61% from the prior year.
- Goodwill improved to $28.6 million in Q4 2025 per VRXA's latest filing, from $26.1 million in the prior quarter.
- Across five years, Goodwill topped out at $28.6 million in Q4 2025 and bottomed at $26.1 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.59 Mn |
| Dec 31, 2024 | 26.08 Mn |